AST SpaceMobile, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AST SpaceMobile, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.40M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Mar 3, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $13.83M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $13.83M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $12.41M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $5.97M | Mar 31, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $7.11M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.84M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.94M | Mar 31, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($341.94M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($300.08M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($87.56M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($31.64M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($30.55M) | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($51.96M) | May 6, 2021 |
| FY2020 | Sep 30, 2020 | ($3.75M) | May 6, 2021 |
| FY2020 | Jun 30, 2020 | ($8.68M) | May 6, 2021 |
| FY2020 | Mar 31, 2020 | $7.77M | May 6, 2021 |
| FY2020 | Dec 31, 2019 | ($2.88M) | May 6, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | ($1.12M) | May 6, 2021 |
| FY2020 | Dec 31, 2019 | ($384.9K) | May 6, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.12M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $28.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $47.49M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $45.62M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $23.44M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.01M | Mar 31, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($71.52M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($126.14M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($148.94M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($156.46M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($80.10M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($22.81M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($905.0K) | May 6, 2021 |
| FY2020 | Sep 30, 2019 | ($692.7K) | May 6, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $174.13M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $118.81M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $57.28M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $15.08M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.12M | Mar 31, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.01B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $954.56M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $360.89M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $438.37M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $443.94M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $99.65M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $231.84M | May 6, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $285.42M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $147.33M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $78.55M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $91.96M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $19.66M | Mar 31, 2022 |
| FY2020 | Sep 30, 2020 | $29.67M | May 6, 2021 |
| FY2020 | Jun 30, 2020 | $25.92M | May 6, 2021 |
| FY2020 | Mar 31, 2020 | $17.59M | May 6, 2021 |
| FY2020 | Dec 31, 2019 | $24.28M | May 6, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $5.00M | May 6, 2021 |
| FY2020 | Sep 30, 2020 | $5.00M | May 6, 2021 |
| FY2020 | Jun 30, 2020 | $5.00M | May 6, 2021 |
| FY2020 | Mar 31, 2020 | $5.00M | May 6, 2021 |
| FY2020 | Dec 31, 2019 | $5.00M | May 6, 2021 |
| FY2020 | Sep 13, 2019 | $5.00M | May 6, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $3.64M | Mar 31, 2023 |
| FY2022 | Dec 31, 2020 | $3.91M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $3.59M | Mar 31, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($831.69M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($489.75M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($189.66M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($102.10M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($70.46M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($39.91M) | Mar 31, 2022 |
| FY2020 | Sep 30, 2020 | ($7.54M) | May 6, 2021 |
| FY2020 | Jun 30, 2020 | ($3.79M) | May 6, 2021 |
| FY2020 | Mar 31, 2020 | $4.89M | May 6, 2021 |
| FY2020 | Dec 31, 2019 | ($2.88M) | May 6, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.34B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $564.99M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $85.62M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $238.59M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $321.79M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $42.78M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $493.1K | May 6, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.76M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $5.00M | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 17.60M | Mar 30, 2020 |